Panic disorder: A Five-Year follow-up study in 52 patients

European Journal of Psychiatry

Volumn 11, Issue 3, 1997, Pages 145-155

  Andersch, Sven ^a,c   Hanson, Lennart ^a   Hällström, Tore ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Psychiatric Outpatient Centre   (Sweden)

Author keywords

Course; Longterm; Panic disorders; Psychiatric comorbidity; Psychopharmacological treatments

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANIC; PATIENT SATISFACTION;

EID: 0030872214     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. (DSM-III)- Washington DC: APA; 1980
2. ANDERSCH S. HANSON L., OTTOSSON JO. et al. Efficacy and safety of alprazolam, imipramine, and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand 83(365 suppl): 18-27. 1991.
3. ANDERSCH S., HANSON L. Comorbidity of panic disorder and social phobia. Eur J Psychiatry 7: 59-64. 1993.
4. BALLENGER JC., BURROWS G., DU PONT R. et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter study trial. 1. Efficacy in short-term treatment. Arch Gen Psychiatry 413-422, 1988.
5. BRADLEY JV. Distribution-Free Statistiacal Tests. London: Prentice Hall; 76-78. 1968.
6. CROSS-NATIONAL COLLABORATIVE PANIC STUDY, Second Phase Investigators. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 160: 191-202, 1992.
7. HAMILTON M. The assessment of anxiety by rating. Br J Med Psychol 32: 50-55, 1959.
8. HAMILTON M. A rating scale for depression. J Neural Neurosurg Psychiatry 23: 56-62, 1960.
9. KATSCHNING H., AMERING M. Panic disorder: the long-term perspective. European Neuropsychopharmacology (September) Vol. 3, nr3:261-262, 1993.
10. KELLY D., GUIRGUISS W., FROMMER E. et al. Treatment of phobic states with antidepressants. Br J. Psychiatry 116:387-398, 1970.
11. LEPINE JP., CHIGNON JM., TEHERANI M. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry , 50; 144-149, 1993.
12. MARKOWITZ JS., WEISSMAN MM., OUELLETTE R. et al. Quality of life in panic disorder: comorbidity. Arch Gen Psychiatry 46; 984-992, 1989.
13. MARKS IM., MATTHEWS AM. Bried standard self-rating for phobic patients. Behav. Res Ther, 17: 263-267, 1979.
14. NOYES R. Jr. REICH J., CHRISTIANSEN J. et al. Outcome of panic disorder: relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 47: 809-818, 1990.
15. ROSENBERG R., BECH P., MELLERGARD M. et al. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipraminetreatment. Acta Psychiatr Scand 83 (365 suppl):39-45, 1991.
16. ROTH M., ARRGYLE N. Anxiety, panic and phobic disorder; an overview J Psychiatr Res, 22 (1 suppl): 34-35, 1988.
17. SHEEHAN D The anxiety disease. New York, NY: The Scribner Book Comp Inc; 1983.
18. SPITZER RI., WILLIAMS JB. Structured clinical interview for DSM-III (SCID). New York, NY: Biometrics Research Department, New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1983.
19. SPITZER RL., WILLIAMS JB. Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorder. J. Psychiatr Res 22:: 55-86, 1988.
20. STEIN MB., SHEA CA., UHDE T. Social phobic symptoms in patients with panic disorder: practical and theoretical implications. Am J Psychiatry 146:235-238, 1989.
21. STEIN MB., TANCER ME., GELERNTER CS. et al. Major depression in patients with social phobia. Am J Psychiatry 147:637-639, 1990.